APIS
Chronic and acute wounds (CTP/skin substitute)
ApprovedCommercial
Key Facts
Indication
Chronic and acute wounds (CTP/skin substitute)
Phase
Approved
Status
Commercial
Company
About SweetBio
SweetBio is a commercial-stage medical device company focused on advanced wound care through its proprietary biomaterial platform combining collagen and Manuka honey. Its two main products, VERIS (daily dressing) and APIS (weekly skin substitute), are designed for chronic and acute wounds, are reimbursed by Medicare, and are supported by clinical evidence demonstrating faster closure times. The company, led by its co-founders, targets the large and growing market for chronic wound management with a differentiated, evidence-based approach.
View full company profile